Essbio SA is a water utility company in Chile. The company is engaged in the production and distribution of drinking water; evacuation and decontamination of sewage and industrial wastewater treatment and technical assistance to rural water systems. It provides Provide high-quality solutions and services in the integral water cycle (potable water, sewage, and decontamination of wastewater) and in the integral management of waste.
2014
1.2K+
Last FY Revenue $251M
Last FY EBITDA $87.9M
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Essbio achieved revenue of $251M and an EBITDA of $87.9M.
Essbio expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Essbio valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $251M | XXX | XXX | XXX |
Gross Profit | XXX | $192M | XXX | XXX | XXX |
Gross Margin | XXX | 76% | XXX | XXX | XXX |
EBITDA | XXX | $87.9M | XXX | XXX | XXX |
EBITDA Margin | XXX | 35% | XXX | XXX | XXX |
EBIT | XXX | $75.9M | XXX | XXX | XXX |
EBIT Margin | XXX | 30% | XXX | XXX | XXX |
Net Profit | XXX | $26.8M | XXX | XXX | XXX |
Net Margin | XXX | 11% | XXX | XXX | XXX |
Net Debt | XXX | $610M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Essbio's stock price is CLP 15 (or $0).
Essbio has current market cap of CLP 386B (or $399M), and EV of CLP 988B (or $1.0B).
See Essbio trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.0B | $399M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Essbio has market cap of $399M and EV of $1.0B.
Essbio's trades at 4.1x EV/Revenue multiple, and 11.6x EV/EBITDA.
Equity research analysts estimate Essbio's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Essbio's P/E ratio is not available.
See valuation multiples for Essbio and 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $399M | XXX | $399M | XXX | XXX | XXX |
EV (current) | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 4.1x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | 11.6x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | 13.5x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | 14.9x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | 39.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEssbio's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Essbio's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Essbio's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Essbio and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | 35% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 46% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
TAQA | XXX | XXX | XXX | XXX | XXX | XXX |
New Sources Energy | XXX | XXX | XXX | XXX | XXX | XXX |
AGL Energy | XXX | XXX | XXX | XXX | XXX | XXX |
APA Group | XXX | XXX | XXX | XXX | XXX | XXX |
Chrysos Corp. | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Essbio acquired XXX companies to date.
Last acquisition by Essbio was XXXXXXXX, XXXXX XXXXX XXXXXX . Essbio acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Essbio founded? | Essbio was founded in 2014. |
Where is Essbio headquartered? | Essbio is headquartered in Chile. |
How many employees does Essbio have? | As of today, Essbio has 1.2K+ employees. |
Is Essbio publicy listed? | Yes, Essbio is a public company listed on SGO. |
What is the stock symbol of Essbio? | Essbio trades under ESSBIO-C ticker. |
When did Essbio go public? | Essbio went public in 2008. |
Who are competitors of Essbio? | Similar companies to Essbio include e.g. TAQA, New Sources Energy, AGL Energy, APA Group. |
What is the current market cap of Essbio? | Essbio's current market cap is $399M |
Is Essbio profitable? | Yes, Essbio is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.